Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

Clinical Trial ID: NCT00177268


This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor: - immunologic assays/flow cytometry - tumor progression/regression - genomic studies - proteomic studies - others germane to the advancement of CTCL treatment


Inclusion Criteria: - 18 or older - able and willing to provide informed consent - diagnosed with CTCL - diagnosed with either atopic dermatitis or eczema Exclusion Criteria: - Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record

  • Start Date


  • Last Updated


  • Sponsor

    University of Pittsburgh

  • Condition Name


Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.